GlassScriptPhysician profile
Bharathi S Voora
NPI 1235152406
$2,019.56
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $586 · 2020: $526 · 2021: $446 · 2022: $462.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $364.82 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $283.08 | 2019-2022 | |
| Novo Nordisk INC | $239.84 | 2019-2022 | |
| Astellas Pharma US INC | $153.67 | 2019-2021 | |
| Glaxosmithkline, LLC. | $149.05 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $142.16 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $126.41 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.23 | 2019-2022 | |
| Lilly USA, LLC | $84.22 | 2022 | |
| Amgen INC. | $75.72 | 2019-2021 | |
| Amarin Pharma, INC. | $67.50 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $37.69 | 2022 | |
| Sanofi Pasteur INC. | $34.31 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $34.25 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.76 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $18.31 | 2019 | |
| Almatica Pharma LLC | $17.40 | 2022 | |
| Ge Healthcare | $14.37 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.79 | 2022 | |
| Scilex Pharmaceuticals INC. | $13.48 | 2021 | |
| Seqirus USA INC | $12.92 | 2019 | |
| Eisai INC. | $12.58 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bharathi Voora listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.